T1	Outcomes 342 381	left ventricular ejection fraction (EF)
T2	Outcomes 386 401	cardiac volumes
T3	Outcomes 505 529	changes in neurohormones
T4	Outcomes 708 884	Temporal changes in plasma renin, angiotensin-II, aldosterone, epinephrine, norepinephrine, B-type natriuretic peptide (BNP), and N-terminal atrial natriuretic peptide (NT-ANP)
T5	Outcomes 1054 1125	EF, cardiac volumes, and risk for subsequent adverse clinical outcomes.
T6	Outcomes 1137 1140	BNP
T7	Outcomes 1158 1164	NT-ANP
T8	Outcomes 1231 1233	EF
T9	Outcomes 1246 1272	end-diastolic volume (EDV)
T10	Outcomes 1289 1308	end-systolic volume
T11	Outcomes 1509 1558	died or experienced heart failure hospitalization
T12	Outcomes 1594 1600	NT-ANP
T13	Outcomes 1662 1676	norepinephrine
T14	Outcomes 1722 1728	NT-ANP
T15	Outcomes 1868 1907	death or heart failure hospitalization.
T16	Outcomes 2020 2022	EF
T17	Outcomes 2027 2049	ventricular dilatation
T18	Outcomes 2124 2148	mortality and morbidity.
T19	Outcomes 2233 2255	ventricular remodeling
